- Home
- APLT vs RPGL Comparison
APLT vs RPGL Comparison
Compare APLT & RPGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APLT | RPGL |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0M | 14.7M |
| IPO Year | 2019 | 2025 |
Fundamental Metrics
Financial Performance| Metric | APLT | RPGL |
|---|---|---|
| Price | $0.11 | $0.27 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.25 | N/A |
| AVG Volume (30 Days) | ★ 9.9M | 2.2M |
| Earning Date | 11-13-2025 | 02-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | $1,000,000.00 | ★ $2,364,485.00 |
| Revenue This Year | $124.18 | N/A |
| Revenue Next Year | $66.67 | N/A |
| P/E Ratio | ★ N/A | $14.88 |
| Revenue Growth | N/A | ★ 339.01 |
| 52 Week Low | $0.10 | $0.23 |
| 52 Week High | $1.50 | $5.19 |
Technical Indicators
Market Signals| Indicator | APLT | RPGL |
|---|---|---|
| Relative Strength Index (RSI) | 25.98 | N/A |
| Support Level | $0.10 | N/A |
| Resistance Level | $0.13 | N/A |
| Average True Range (ATR) | 0.02 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 7.66 | 0.00 |
Price Performance
Historical ComparisonAbout APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About RPGL Republic Power Group Limited Class A Ordinary Shares
Republic Power Group Ltd is a Singapore-based provider of customized software development, technology solutions, consulting, and technical support services. The company specializes in real-time monitoring, resource allocation, surveillance, and threat detection software, with capabilities in AI and IoT integration to provide services to corporate clients and government agencies.